Therefore, as the T cell epitopes have the potential to steer the immune response without causing the detrimental process of IgE crosslinking on mast cells and/or basophils causing the allergic reaction, active immunotherapy using T cell epitopes/peptides may be an attractive option for cow’s-milk-allergic patients (both as a preventive as well as a therapeutic approach). Here, IGHE is linked to allergic disease.